Projects per year
Personal profile
Biography
Greg Moore is Head of IBD at Monash Medical Centre in Melbourne and a Senior Lecturer in the Department of Medicine, Monash University.
He is Chair of the Austrlaian Inflammatory Bowel Diseases Association and a Board member of Crohn's and Colitis Australia and Chair of the Medical and Scientific Committee of CCA.
He graduated from Monash University and completed Gastroenterology training at Monash Medical Centre and St. Vincent's Hospital Melbourne.
He then undertook a basic science PhD at the University of Melbourne, and returned to found the Inflammatory Bowel Diseases Unit at Monash Medical Centre in 2007 where he oversees a multi-disciplinary IBD clinic providing tertiary referral services to the South East of Melbourne and country Victoria.
Greg combines private practice with coordinating clinical trials, undertaking ongoing research, supervising PhD and BMedSci students, and is an active undergraduate and post-graduate teacher.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn’s Disease
Moore, G. (Primary Chief Investigator (PCI))
9/12/24 → 8/12/29
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants with Moderately to Severely Active Ulcerative Colitis
Moore, G. (Primary Chief Investigator (PCI))
24/09/24 → 23/03/27
Project: Research
-
A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Moore, G. (Primary Chief Investigator (PCI))
27/05/24 → 26/05/29
Project: Research
-
A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
Sandhu, M. (Primary Chief Investigator (PCI)) & Moore, G. (Primary Chief Investigator (PCI))
15/02/24 → 14/02/29
Project: Research
-
A Phase 2, Multicenter, Double-blind, Two-arm Study of Subcutaneous RVT-3101 for the Treatment of Subjects with Moderate to Severe Active Crohn’s Disease
Moore, G. (Primary Chief Investigator (PCI))
1/12/23 → 30/11/28
Project: Research
-
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Yu, N., Lee, T., Tassone, D., Vogrin, S., Phan, S., Wu, D. M., Zhang, J., Wang, L., Tjahyadi, J., Dutt, K., Liou, H., Basnayake, C., Wright, E., Niewiadomski, O., Lust, M., Schulberg, J., Kamm, M. A., Connell, W., Thompson, A. J. & Hilmi, I. & 7 others, , Nov 2024, In: Internal Medicine Journal. 54, 11, p. 1856-1866 11 p.Research output: Contribution to journal › Article › Research › peer-review
-
Characteristics of the Kono-S anastomosis in Crohn's disease patients using intestinal ultrasound
Low, E. S. L., Greeve, T., Boyapati, R. K., Moore, G. T. & Shelton, E., 1 Sept 2024, In: European Journal of Gastroenterology & Hepatology. 36, 9, p. 1150-1152 3 p.Research output: Contribution to journal › Letter › Other › peer-review
1 Citation (Scopus) -
Colonic cytomegalovirus DNA detection by polymerase chain reaction does not influence outcomes in inflammatory bowel disease and immunosuppressed cohorts
Nguyen, P., Shrestha, A., Sane, N., Abeywickrama, D., Holt, D. Q., Bell, S., Moore, G. & Goldberg, R., Feb 2024, In: Internal Medicine Journal. 54, 2, p. 283-289 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer
Freckelton, J., Rajagopalan, A., Moore, G. T. & Croagh, D., May 2024, In: Pancreas. 53, 5, p. e405-e409 5 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Human Amniotic Epithelial Cell Transplantation is Safe and Well Tolerated in Patients with Compensated Cirrhosis: A First-in-Human Trial
Lim, R., Hodge, A., Warner, S., Moore, G. T., Correia, J., Krause, M., McDonald, H., Chan, S. T., Goonetilleke, M., Lyon, S. M. & Sievert, W., Jun 2024, In: Stem Cells Translational Medicine. 13, 6, p. 522-531 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus)
Activities
- 1 Membership of an advisory panel/policy group/ board
-
Crohn's and Colitis Australia (External organisation)
Moore, G. (Member)
2010 → …Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board